Health-Related Quality of Life after Cystectomy and Urinary Diversion for Bladder Cancer

Table 1

Comparison of bladder cancer specific HRQOL instruments.

	Target population	No of items	Domains				Validation
			General well-being	Bowel; (no. of items)	Urinary; (no. of items)	Sexual; (no. of items)
Bladder Cancer Index (BCI)	Localized bladder cancer	36	No	Yes (10)	Yes (14)	Yes (12)	Test-retest 0.73–0.95, internal consistency 0.77–0.91
EORTC QLQ-BLS24	Superficial bladder cancer (Ta, T1, CIS)	24	No	Yes	Yes (including items related to intravesical treatment: fever, malaise, bother of repeated cystoscopies)	Yes	Pending
EORTC QLQ-BLM30	Invasive bladder cancer (T2, T3, T4a/b)	30	No	Yes	Yes (including items related to urostomy probems, catheterization)	Yes	Pending
FACT-BL	Bladder cancer	45	FACT-G	Yes (4)	Yes (3) + Stoma (2)	Yes (2)	FACT-G: test-retest 0.82–0.92
FACT-VCI	Bladder cancer, after radical cystectomy	45	FACT-G	Yes (4)	Yes (4)	Yes (4)	Test-retest 0.79, internal consistency 0.83–0.85